Ma. Rigby et al., IMMUNOGENICITY OF A PEPTIDE FROM A MAJOR NEUTRALIZING DETERMINANT OF THE FELINE IMMUNODEFICIENCY VIRUS SURFACE GLYCOPROTEIN, Vaccine, 14(12), 1996, pp. 1095-1102
The third variable region (V3) of the feline immunodeficiency virus (F
IV) surface glycoprotein is predicted to have similar physical propert
ies to that of HIV and has been shown to contain immunodominant and ne
utralizing epitopes. Immunological characteristics of this region were
investigated further using a peptide corresponding to the middle of t
he putative FIV V3 loop. The peptide was recognized in ELISA by sera f
rom the majority of naturally FIV-infected cars, and absorbed a signif
icant fraction of the virus neutralizing activity front a pool of sera
of cats naturally infected with FIV, confirming the immunogenic natur
e of this region. A sheep immunized with an octameric form of the pept
ide (multiple antigenic peptide, MAP) in Freund's complete adjuvant ge
nerated neutralizing antibody to a higher titre than infected cats. Ho
wever, immunization of cats with the same MAP in an acceptable adjuvan
t formulation (Quil A) induced antibody and cytotoxic T-cell responses
to the immunizing peptides but only minimal neutralizing activity. Th
ese responses did not significantly alter the kinetics of infection or
the proviral load after challenge with a homologous strain of FIV, co
mpared with naive controls. While the potential efficacy of peptide va
ccines to lentiviruses remains to be determined, this study shows that
the immune response evoked may be highly dependent on the delivery an
d adjuvant regime used. Copyright (C) 1996 Elsevier Science Ltd.